Respiratory Syncytial Virus

Discussion in 'Stocks' started by nursebee, Aug 15, 2014.

  1. nursebee

    nursebee

    Stoned,
    Your prior ANALysis on stocks I picked, how good was it?
    How much money did you leave on the table?
    How much did you gather while bashing my stock/company?

    Your ANALysis on INO, can you explain their market to me?
    THeir potential sales total, number of customers? Justify future market cap?

    Your ANALysis of NVAX? Can you explain your not liking it as a cancer vax?
    Can you explain ultra conservative Vanguard buying 3M shares?

    Do you have a therapist to discuss your trading problems with?
    Does this therapist help you fashion better arguments?

    I'm all for honest discussion and debate, but Navy Seals just has me concerned of CEO pumping to emotional blank wads
     
    #91     Aug 17, 2015
  2. nursebee

    nursebee

  3. nursebee

    nursebee

    More positive data
    nvax.PNG
     
    #93     Sep 29, 2015
  4. nursebee

    nursebee

    pic
     
    • nvax.PNG
      nvax.PNG
      File size:
      327.8 KB
      Views:
      15
    #94     Apr 13, 2016
  5. nursebee

    nursebee

    Novavax has continued to execute well, I won't bother to recap. I'd suggest those interested read the shareholder letter here: http://www.envisionreports.com/NVAX/2016/26F18MA16E/default.htm?voting=false

    I have followed this company for years. I recall when the percentage of shares owned by institutions was in the 50% range. Following shows general dates and % ownership over time.

    8/15 67.87%
    2/16 73.56
    3/16 75.73
    4/19/16 77.11
    5/14/16 79.49
    5/17/16 83.08%
     
    #95     May 17, 2016
  6. nursebee

    nursebee

  7. nursebee

    nursebee

  8. nursebee

    nursebee

  9. nursebee

    nursebee

    I rarely so boldly or openly make market calls
    Today I find myself a bit emotional and offer you this gift.
    Your own success or failure is up to you. Do not go blindly. If you are blind, do a bit of research. On your own, dont trust mine.

    There are some PRIME flippin "PRICE DRIVERS" (lol) for this company over the next two months, likely August.

    They are widely expected to announce phase 3 clinical trial data for an unmet worldwide medical need.

    The spring is tight.

    Governor and Senator of MD toured the facility today.

    Good news is an easy $15 from here.
    The roulette wheel is spinning, lay down your bets.
     
    #99     Jul 18, 2016
  10. nursebee

    nursebee

     
    #100     Jul 29, 2016